The report provides market dynamics and trends related to the global disposable syringes market. In addition, it presents estimations and forecast of the market. It includes revenue generated from the sales of disposable syringes used in vaccination, injecting drugs, and collecting blood samples. For the purpose of analysis, the disposable syringes market size is studied on the basis of product type, application, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into conventional disposable syringes and safety disposable syringes. By application, it is bifurcated into immunization injections and therapeutic injections. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

Burns are injuries to tissues or skin caused by radiation, heat, friction, chemicals, or electricity. Burn care treatment includes relieving pain, maintaining body fluids & electrolytes, preventing infection, and calorie intake during the healing process. The report provides market dynamics and trends related to the global burn care market. In addition, it presents the estimations and forecast of the market. The valuations comprise revenue generated from burn care products such as advanced burn care, biologics, traditional burn care, and others. The study estimates the revenue generated from the sales of burn care products; however, it excludes the burn care service revenue. Furthermore, the report excludes revenue generated from post-sale services of burn care products.

The report provides market dynamics and trends related to the blood market. It includes revenue generated from the sales of products, which are used to collect and process different components of blood such as source plasma, albumin, and hyperimmune serum. The products which are covered in the report include whole blood collection systems, whole blood collection reagents, source plasma collection systems, source plasma collection reagents, and others. The blood market is segmented into product, end user, and region. On the basis of product, it is classified into whole blood collection and processing, source plasma collection, blood typing products, and blood screening products. Furthermore, all these segments are further classified into sub-segments. For instance, the whole blood collection segment is classified into whole blood collection systems and whole blood collection consumables. The source plasma collection segment is classified into source plasma collection systems and source plasma collection consumables. In addition, the blood typing products are further bifurcated into blood typing systems, blood typing reagents. The blood screening products are divided into blood screening systems, and blood screening reagents.

Blood bank is a place where blood is collected, separated, processed, tested, and stored for future use. In addition, a blood bank provides red blood cells, whole blood, blood plasma, blood platelet and other blood products to the healthcare providers. The report provides market dynamics and trends related to the global blood bank market. In addition, it presents the market estimations and forecast. The study estimates the revenue generated from blood services provided by blood banks such as blood collection, processing, testing, storage, and distribution. A blood banks distributes blood and blood components to hospitals4, ambulatory surgery centers, pharmaceutical companies, clinics & nursing homes, and others. However, the report does not include revenue generated from blood banking devices as well as plasma derivatives and other blood products.

The report provides market dynamics and trends related to the global anti-viral therapies market. In addition, it presents the market estimations and forecast. The study estimates the revenue generated from the sales of the drugs and therapies approved for the treatment of viral infections. The valuations comprise revenue generated from usage of drugs and therapies, in HIV, herpes, hepatitis, and influenza. However, the report does not include revenue generated by dealers, traders, or brokers of the market.

The factors that drive the growth of the anesthesia machinery market include technological advancements in anesthesia monitoring, rise in number of surgical procedures and increase in geriatric population. However, high cost of installation and maintenance and regulatory compliance restrain the growth of the anesthesia machinery market. Furthermore, rise in demand for quality healthcare monitoring and untapped emerging markets are anticipated to provide lucrative opportunities for anesthesia machine manufacturers in the future.

The global Alzheimer ’s disease (AD) diagnostics and therapeutics market is currently composed of five major marketed drugs, donepezil, galantamine, rivastigmine, memantine, and combination of donepezil/memantine; a multitude of brain imaging diagnostics tests; and a highly invasive technique of CSF analysis for AD biomarker identification. The end product/service offered in this market today is the same as what was offered about a decade ago. During the last decade, there were many drugs that made it to the late stages of clinical trials, but almost all of them were rejected for market approval, due to toxicity and safety issues. Today, many drugs are again in the late pipeline stages of drug development for AD. In fact, there are more candidates than ever and there are many novel drug applicants, aimed at addressing the actual pathological cause of AD, which the currently marketed drugs are unable to address. Additionally, the current modality in advanced and late AD diagnosis is composed of brain imaging studies, which sometimes need to be conducted over a wide timespan of months to arrive at the correct diagnosis. The second line of diagnosis is composed of CSF tests, which requires an invasive procedure of lumbar puncture.

Allergy is a condition in which the body immune system reacts abnormally to a foreign substance. The major factors for the growth of the allergy treatment market include the increasing burden of various types of allergies, increased investment by the manufacturers on the development of novel allergic treatments, and rising importance for self-medication. As per the data published by the American College of Allergy, Asthma & Immunology, allergies are the sixth leading cause of chronic illness in the United States, with an annual cost in excess of USD 18 billion, and more than 50 million Americans suffer from allergies each year. Several pharmaceutical companies are focusing even more on global strategies for developing and marketing their products. Therefore, their main goal is to understand the present regulatory situation for allergen products from a worldwide perspective, as this directly affects the availability of these products to patients across the world.

The NPWT market is currently being driven by factors, such as the rising prevalence of chronic wounds and growing diabetic population. This leads to a higher number of diabetic foot ulcers and increase in the geriatric population across the world. Few factors are hindering the market growth, which includes the high cost of the NPWT therapy, and complications associated with NPWT devices. The market is witnessing continuous advancements in the products and technologies used. Companies, such as 3M (Acelity LP Inc.), Smith & Nephew, and ConvaTec Group PLC, hold large market shares, in the NPWT devices. Single-use NPWT products are gaining popularity over traditional products in the area of wound care treatment. For example, key players, like Smith & Nephew, have launched a single-use NPWT, PICO, which has gained tremendous popularity, worldwide. Fur ther, ConvaTec Inc. launched the Avelle™ Negative Pressure Wound Therapy (“NPWT”) system. It is the first and only device of this technology, combining negative pressure with the advantages of Hydrofiber® technology. Thus, advancements in technology in negative pressure wound therapy products may drive the market growth, during the forecast period.